Compounds > pectolinarin
Page last updated: 2024-09-05

pectolinarin and nafamostat

pectolinarin has been researched along with nafamostat in 1 studies

Compound Research Comparison

Studies
(pectolinarin)		Trials
(pectolinarin)		Recent Studies (post-2010)
(pectolinarin)		Studies
(nafamostat)		Trials
(nafamostat)		Recent Studies (post-2010) (nafamostat)
2601564054198

Protein Interaction Comparison

ProteinTaxonomypectolinarin (IC50)nafamostat (IC50)
Ubiquitin-like modifier activating enzyme 2Homo sapiens (human)7.47
SUMO1 activating enzyme subunit 1Homo sapiens (human)7.47
ubiquitin-like modifier-activating enzyme 1Homo sapiens (human)14
SUMO-conjugating enzyme UBC9Homo sapiens (human)7.47
ubiquitin-conjugating enzyme E2 NHomo sapiens (human)14
ubiquitin-conjugating enzyme E2 variant 1 isoform aHomo sapiens (human)14
ProthrombinHomo sapiens (human)1.9
Complement C1r subcomponentHomo sapiens (human)0.8
PlasminogenHomo sapiens (human)2.9
Cationic trypsinBos taurus (cattle)0.017
Serine protease hepsinHomo sapiens (human)0.005
Trypsin-1Homo sapiens (human)0.017
Complement C1s subcomponentHomo sapiens (human)0.029
Hepatocyte growth factor activatorHomo sapiens (human)0.15

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, J; Chen, W; Choudhry, N; Xu, D; Yang, Z; Zanin, M; Zhao, X1

Reviews

1 review(s) available for pectolinarin and nafamostat

ArticleYear
Chinese Therapeutic Strategy for Fighting COVID-19 and Potential Small-Molecule Inhibitors against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Journal of medicinal chemistry, 2020, 11-25, Volume: 63, Issue:22

    Topics: Antiviral Agents; China; Coronavirus Protease Inhibitors; COVID-19; COVID-19 Drug Treatment; Drugs, Chinese Herbal; Humans; Medicine, Chinese Traditional; SARS-CoV-2; Small Molecule Libraries

2020